Evidence map›Paper›PMID 41629492›Full record

ArticleScientific reports2026

Eco-friendly synthesis of Balanites aegyptiaca-derived selenium nanoparticles: extract and assessment of their anticancer, antimicrobial, cytogenetic and molecular docking insights.

Mohamed I M El-Zaidy, Heba G Ayoub, Gehan El-Akabawy, Amira A Ibrahim, Mohamed Abdel-Haleem

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed I M El-ZaidyDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. mibrahem@science.zu.edu.eg.
Heba G AyoubHigh Technological Institute for Applied Health Sciences, K 36 Cairo-Ismailia Road, Cairo, Egypt.
Gehan El-AkabawyDepartment of Basic Medical Sciences, College of Medicine, Ajman University, Ajman, United Arab Emirates.
Amira A IbrahimBotany and Microbiology Department, Faculty of Science, Arish University, Al-Arish, 45511, Egypt. amiranasreldeen@sci.aru.edu.eg.
Mohamed Abdel-HaleemDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. mahafez@zu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reports the eco-friendly synthesis of selenium nanoparticles (SeNPs) using the methanolic extract of Balanites aegyptiaca mesocarp and evaluates their biological activities. The synthesized spherical SeNPs (average size: 2.82 nm) were characterized by TEM, FESEM, and UV-Vis spectroscopy, confirming that phenolic compounds serve as both reducing and stabilizing agents. HPLC analysis revealed eight major phenolics, with gallic acid, chlorogenic acid, and daidzein being the predominant compounds. The SeNPs exhibited strong cytotoxicity against HCT-116 colorectal cancer cells (IC₅₀ = 30.03 µg/mL), potent antibacterial activity against Klebsiella pneumoniae, Escherichia coli, and Enterococcus faecalis, and induced concentration-dependent cytogenetic effects in Vicia faba root tips. Molecular docking studies suggested that phenolic compounds effectively interact with the CDK4 active site, supporting their potential anticancer properties. These findings highlight B. aegyptiaca-derived SeNPs as promising candidates for biomedical applications.

Indexed as

Anti-Infective AgentsAntineoplastic AgentsMetal NanoparticlesNanoparticlesPlant ExtractsSeleniumGreen Chemistry TechnologyHCT116 CellsHumansMolecular Docking SimulationAnti-Infective AgentsAntineoplastic AgentsPlant ExtractsSeleniumAnticancer activityAntimicrobial activityBalanites aegyptiacaChromosomal aberrationsPhenolic compoundsSeNPs

Identifiers

PMID41629492
PMCPMC12868762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.